Market Insight

The Irish Independent reports that Bluedrop Medical secured approximately $1.2М in funding from Enterprise Ireland.
Galway-based Bluedrop develops technology aimed at reducing the rate of preventable amputations for people living with diabetes. It develops of an internet of things (IOT)-enabled devic

Boston Scientific announced that it invested $1.5 billion in transcatheter aortic valve replacement (TAVR) developer MiRus.
Marlborough, Massachusetts–based Boston Scientific now has an equity stake in MiRus worth approximately 34%. The deal also includes an exclusive option to acquire MiRus’ Siegel

Xeltis has gained a European CE mark for aXess, with 12-month pivotal data of the vascular access graft for haemodialysis demonstrating strong and higher secondary patency versus conventional arteriovenous grafts (AVGs).
Xeltis’s aXess is a bioabsorbable graft for haemodialysis that is injected under

EmStop announced that it kicked off the CAPTURE-2 FDA investigational device exemption (IDE) study of its embolic protection system (EPS).
CAPTURE-2 evaluates the safety and performance of the EPS, an investigational device for cerebral embolic protection designed to capture and remove debris that in